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This raises the possibility that the TGFb receptor family
Activation of the type I TGFb receptor (TbR-I) requires represents a link in the evolution of tyrosine kinases.
phosphorylation of a regulatory segment known as the Many receptor tyrosine kinases are activated by phos-
GS region, located upstream of the serine/threonine phorylation of the activation loop or segment, a central
kinase domain in the cytoplasmic portion of the recep- structural element within the kinase domain (Johnson
tor. The crystal structure of a fragment of unphosphor- et al., 1996). This is not the case for TbR-I. Instead, kinase
ylated TbR-I, containing both the GS region and the activation is achieved by multiple phosphorylations in
catalytic domain, has been determined in complex the GS region, upstream of the catalytic domain (Wrana
with the FK506-binding protein FKBP12. TbR-I adopts et al., 1994). This mechanism of activation is unique to
an inactive conformation that is maintained by the the TGFb receptor family, and there is consequently no
unphosphorylated GS region. FKBP12 binds to the GS structural precedent for understanding the molecular
region of the receptor, capping the TbR-II phosphory- basis for the control of TbR-I kinase activity.
lation sites and further stabilizing the inactive confor- Several different type I receptors have been shown
mation of TbR-I. Certain structural features at the cat- to interact strongly with the immunophilin FKBP12 (Wang
alytic center of TbR-I are characteristic of tyrosine et al., 1994; Okadome et al., 1996). FKBP12 plays a
kinases rather than Ser/Thr kinases. crucial role in mediating the effects of the immunosup-
pressant drugs FK506 and rapamycin (Schreiber, 1991).
Introduction Its normal biological function is not completely estab-
lished, and the physiological relevance of the binding
Transforming growth factor b (TGFb) is the founding of TbR-I by FKBP12 remains controversial (Charng et
member of a set of secreted, dimeric, peptide growth
al., 1996; Shou et al., 1998). FKBP12 binding has been
factors that includes the TGFbs, activins, inhibins, bone
shown to inhibit TGFb receptor±mediated signaling
morphogenic proteins (BMPs), and others (MassagueÂ ,
(Wang et al., 1996; Chen et al., 1997; Stockwell and1990; Roberts and Sporn, 1990). Once secreted and
Schreiber, 1998b), and it has been proposed thatactivated, TGFb signals by engaging a specific cell sur-
FKBP12 serves to eliminate spurious signaling causedface receptor composed of two related transmembrane
by receptor oligomerization in the absence of ligandserine/threonine kinases, called the type I and type II
(Chen et al., 1997).TGFb receptors (TbR-I and TbR-II), respectively (Heldin
A detailed mechanistic understanding of the regula-et al., 1997; MassagueÂ , 1998). TbR-I and TbR-II have
tion of the TGFb family receptors has been hindered bythe same basic structural elements: a cysteine-rich
the lack of three-dimensional structural information onN-terminal extracellular domain, which is involved in li-
this class of protein kinases. We now present the crystalgand binding; a single transmembrane helix; and a C-ter-
structure of the unphosphorylated cytoplasmic domainminal cytoplasmic kinase domain. In addition, TbR-I, but
of the type I TGFb receptor (TbR-I) in complex withnot TbR-II, contains a regulatory segment in its cyto-
FKBP12. The TbR-I kinase adopts an inactive conforma-plasmic juxtamembrane region called the GS region or
tion, which is maintained by interactions between thedomain (named for the conserved 185TTSGSGSGLP194
GS region, the activation segment, and the N-terminalsequence at its center). The basic mechanism of TGFb
lobe of the kinase. The structure shows that phosphory-receptor activation has been established (Wrana et al.,
lation of the GS region would disrupt its conformation,1994; Chen and Weinberg, 1995). The type II receptor
binds ligand first and then recruits the type I receptor. thereby relieving the inhibitory interactions. FKBP12
Next, TbR-II phosphorylates serine and threonine resi- binds to the GS region, protecting the TbR-II phosphory-
dues in the GS region of TbR-I (Wrana et al., 1994). lation sites and stabilizing the inhibited conformation of
the kinase. Finally, an intriguing structural connection
is established between the catalytic center of TbR-I and‖ To whom correspondence should be addressed (e-mail: kuriyan@
rocky2.rockefeller.edu). those of tyrosine kinases.
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Figure 1. The Structure of TbR-I in Complex
with FKBP12
All elements of secondary structure dis-
cussed in the text are labeled. This figure and
all subsequent ribbon diagrams were gener-
ated using RIBBONS (Carson, 1991).
Results and Discussion (41% identity with TbR-II) allows the structure presented
here to serve as a useful model for TGFb receptors in
general.Structure Determination and Basic Architecture
of the TbR-I Kinase
A fragment comprising residues 162±503 of human
TbR-I (hereafter referred to as TbR-I) was expressed The TbR-I Kinase Domain Is in
an Inactive Conformationand purified from insect cells. The TbR-I protein forms
a stable complex (1:1) with human FKBP12. Crystals of Comparison of the structure of the TbR-I kinase domain
with that of the active Ser/Thr kinase PKA reveals severalthe complex are triclinic, with four complexes in the
asymmetric unit. The structure of the complex (Figure 1) features in the TbR-I kinase that would impair its cata-
lytic activity. The catalytic segment is a highly conservedwas solved by multiple isomorphous replacement (MIR,
see Experimental Procedures). The current model has and centrally located loop within the protein kinase do-
main that connects the E helix and the activation seg-been refined to an R value of 24.9% and a free R value
(BruÈ nger, 1992) of 26.9%, using data to a resolution ment (Figures 1 and 2). If TbR-I and PKA are aligned
using only their catalytic segments (residues 331±351of 2.6 AÊ .
The core region of the TbR-I catalytic domain (resi- in TbR-I, 164±184 in PKA), it becomes apparent that the
N lobe of TbR-I is shifted away from the active configura-dues 205±500) adopts a canonical protein kinase fold,
similar to that first seen in the structure of the cAMP- tion seen in PKA (Figure 3A). The bulk of this movement
consists of a 78 rigid body rotation about an axis roughlydependent protein kinase PKA (Knighton et al., 1991).
A smaller N lobe is involved in ATP binding, and a larger perpendicular to the N-terminal b sheet of the kinase
domain. This rotation results in a shearing of the activeC lobe is required for substrate recognition. The N lobe
is dominated by a twisted, five-stranded b sheet, while site (Figure 3B). Lys-232 and Glu-245, two catalytic
groups contributed by the N lobe, are moved by z3 AÊthe C lobe is largely helical (Figure 1). The N-terminal GS
region forms a helix-loop-helix segment that is packed with respect to residues contributed by the catalytic
segment, namely Asp-333, Asn-338, and Asp-351.tightly onto the outer surface of the b sheet of the N
lobe. FKBP12 is bound to the GS region. In the N lobe, Protein kinases engage ATP in a deep groove between
their N and C lobes. In TbR-I, the rotation and distortiontype I receptors contain an insertion between strands
b4 and b5 (the L45 loop) that determines Smad substrate of the N lobe damages the integrity of the ATP-binding
site. In particular, the phosphate and magnesium recog-specificity (Feng and Derynck, 1997; Chen et al., 1998).
The L45 loop extends out into solution, where it is well nition pocket is constricted. The nucleotide from the
PKA structure can be docked into TbR-I based on thepositioned to interact with other proteins (Figure 4B).
Close sequence similarity between various type I recep- alignment of catalytic segments. When this is done, it
becomes apparent that the space occupied by the phos-tors (the TbR-I catalytic domain shares 90% identity
with activin receptor-IB, 68% with BMP receptor-IB) and phate groups in the nucleotide-binding site of PKA is
occluded in TbR-I by elements of the N lobe b sheetbetween type I and type II receptor kinases domains
Crystal Structure of the TbR-I±FKBP12 Complex
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Figure 2. An Alignment of TbR-I with Other Protein Kinases
The sequence of the TbR-I cytoplasmic domain is aligned with that of other type I receptors and with TbR-II. Structure-based alignments
against PKA and IRK are also shown. Secondary structural elements of TbR-I, colored as in Figure 1, are shown directly above the alignment,
with cylinders indicating helices and arrows indicating b strands. The secondary structure of PKA is shown below the alignment. Structural
elements are named as in PKA (Knighton et al., 1991). In the alignment, red represents absolute sequence identity over all sequences present
in that part of the alignment, while yellow represents a similarity score of 5 using the method of Livingston and Barton (1996). Alignment
generated using Alscript (Livingston and Barton, 1996).
(Figure 3C). Lys-232 blocks the binding of the a-phos- form of autoinhibition when compared with the larger
distortions seen in certain other inhibited kinases (Huphate, Phe-216 blocks the b-phosphate, and Phe-216
together with Arg-372 block the g-phosphate. et al., 1994; Goldberg et al., 1996; Russo et al., 1996).
Consistent with this, unphosphorylated TbR-I displaysThe role of Arg-372 in disrupting the active site is
particularly interesting. Arg-372 is a residue in the activa- very low but detectable activity in kinase assays (data
not shown). This small amount of activity, while insignifi-tion segment that extends its side chain into the catalytic
center to form an ion pair with Asp-351 (Figure 3B), a cant in any catalytic sense, has been sufficient in previ-
ous studies to map phosphorylation sites on down-ligand for a crucial magnesium ion (Armstrong et al.,
1979; Zheng et al., 1993). The Arg-372±Asp-351 interac- stream Smad proteins (Kretzschmar et al., 1997).
tion effectively disrupts magnesium binding. The TbR-
I±FKBP12 crystals used in this study were grown in Structural Stabilization of the Inactive Conformation
In TbR-I, the catalytically inactive conformation appearsthe presence of AMP±PNP and magnesium. Convincing
density for the nucleotide and Mg21 ions has not been to be maintained by interactions between the N lobe of
the kinase, the GS region, and the activation segment.obtained, which is consistent with the partial blockage
of the ATP-binding site observed in this structure. In particular, the GS region and the activation segment
act together to position and stabilize the aC helix suchThe observed misorientation of the active site and
ATP-binding groove in TbR-I appears to be a fairly gentle that it tips into and pins back the b sheet of the N
Cell
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Figure 3. The TbR-I Kinase Adopts an Inac-
tive Conformation
TbR-I and PKA (Zheng et al., 1993) were
aligned for this figure using their kinase cata-
lytic segments.
(A) The TbR-I-PKA alignment viewed from
above the b sheet of the N lobe. The N lobe b
sheet of TbR-I is rotated with respect to PKA.
(B) A view of the TbR-I-PKA alignment show-
ing the active site and several conserved cat-
alytic residues. The proteins are colored as
in (A), with ATP from the PKA structure repre-
sented in red sticks. The aligned catalytic
segments have been highlighted. The two
metal ions found in the PKA structure are
shown as black balls. TbR-I residues are col-
ored green, and PKA residues are colored
yellow. Side chains are labeled using TbR-I
numbering. The corresponding residues in
PKA are K72, E91, D166, N171, and D184.
The TbR-I active site is sheared relative to
PKA, and red arrows indicate the resulting
displacements of K232 and E245. In addition,
the Arg-372±Asp-351 ion pair disrupts the in-
nermost metal-binding site.
(C) A comparison of the PKA and TbR-I ATP-
binding sites. PKA is shown above in complex
with ATP and metal ions. TbR-I is shown be-
low, with the nucleotide and metal ions from
PKA docked into its active site based on the
catalytic segment alignment. The regions
boxed to the left have been magnified on the
right. Electrostatic surface representations of
the ATP-binding pockets have been included,
with blue indicating positive potential and red
indicating negative potential. The two metal
ions are shown in cyan. The surface represen-
tations show that there is no room for the ATP
phosphate groups or the innermost metal ion
in the TbR-I nucleotide-binding pocket. These
and other molecular surfaces were generated
using GRASP (Nicholls et al., 1991).
lobe (Figure 3A). Relative to its configuration in active in the absence of FKBP12 binding and is not induced
by it. The loop connecting aGS1 and aGS2 (the GSkinases, the C-terminal portion of aC lies further from
the b sheet by 2±3 AÊ , while the N-terminal end is pressed loop) spans the conserved 185TTSGSGSGLP194 sequence
motif, which contains sites that are phosphorylated bycloser to a similar extent.
We refer to the two helices in the GS region as aGS1 the type II receptor. The GS loop forms a wedge that
inserts into the space between the aC helix and the b4and aGS2. Helix aGS2 nestles in the groove created by
the twisted b sheet of the N lobe and engages in an strand of the N lobe, with the side chain of Ser-191
extending into the very base of the cavity (Figure 4B).array of contacts with the top of the b sheet and the
amphipathic aGS1 helix, forming a hydrophobic core There is a two-residue insertion in the kinase domain
that is conserved among type I receptors, which maps(Figure 4A). FKBP12 binds directly to the GS2 helix and
appears to further reinforce the conformation of the GS to the C terminus of the TbR-I aC helix (Figure 2). This
insertion allows the C helix to move away from strandregion. The network of hydrophobic interactions within
the GS region suggests that its conformation is stable b4, creating the space required for GS loop insertion.
Crystal Structure of the TbR-I±FKBP12 Complex
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Figure 4. The Inhibited Conformation of TbR-I Is Maintained by the GS Region and the Activation Segment
(A) A ribbon drawing showing the hydrophobic interactions made between the GS region helices and the top of the kinase b sheet. TbR-I is
viewed from above the kinase N lobe. Thr-204, the site of a constitutively activating TbR-I mutation (Wieser et al., 1995), is indicated.
(B) A ribbon drawing of the complex showing interactions between the GS loop and the TbR-I kinase, as well as contacts formed between
FKBP12 and TbR-I. Several interacting residues are shown, with hydrogen bonding indicated by dashed purple bonds. The L45 loop is
indicated.
(C) TbR-I viewed from an oblique angle above the kinase N lobe. The TbR-II phosphorylation sites are indicated, as are several residues
involved in ionic or polar interactions that stabilize the placement of the C helix. The movement of the C helix and the N lobe b sheet into an
active conformation appears to be blocked by the GS loop and a short stretch within the activation segment. These two steric blockers have
been colored magenta.
(D) The same view as in (C), with a molecular surface representation of the kinase C lobe. The aC side chains have been included to indicate
the space occupied by the helix. The outward rotation of the C helix and the N lobe b sheet is blocked by the barrier created by the activation
segment.
The TbR-I activation segment forms a b hairpin (con- helix. The activation segment also contacts the N lobe
b sheet directly. The side chain of Phe-216, a residuesisting of strands b9 and b10) that is supported by a
one and a half turn extension of the aF helix (Figures 1 in the loop connecting strands b1 and b2, is in van der
Waals contact with the aliphatic portion of Arg-372. Anyand 2). b9 and b10, together with strand b6, form a three-
stranded sheet that cradles the C helix and appears to activating rotation of the kinase N lobe would produce
a steric clash between these residues.stabilize its rotated conformation (Figures 1, 4C, and
4D). Residues from this b sheet interact with aC over
much of its length. The side chains of Ile-248 and Val- Activation of TbR-I
The unphosphorylated GS loop adopts an unusual con-252 from aC make van der Waals contacts with Ile-329
and Pro-327 from strand b6. Glu-247 positions Arg-244 formation in which the protein chain undergoes two 1808
turns in the space of seven residues (Figures 4A andto interact with Asp-366 in strand b10. Asp-366, in turn,
fixes Arg-357 from b9 to properly hydrogen bond with 4B). It is unlikely that the GS loop will maintain this
partially buried and tightly folded conformation uponThr-251.
The interactions between the aC helix, the GS region, the addition of bulky and negatively charged phosphate
groups. Release of the GS region from this internallyand the activation segment restrict the motion of the
helix (Figure 4C and 4D). Two elements (residues 368± bound configuration will presumably relieve the inhibi-
tory effects of the GS loop on the C helix and N-terminal372 in the activation segment and residues 189±192 in
the GS loop) act as steric blockers that cage the aC kinase b sheet.
Cell
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Figure 5. A Comparison of the FKBP12±FK506 and FKBP12±TbR-I Complexes
A surface representation of FKBP12 bound to FK506 is shown to the left (Wilson et al., 1995). To the right is shown a surface representation
of FKBP12 bound to the TbR-I GS region. Leu-195 and Leu-196 are bound in the same hydrophobic pocket used to engage immunosuppressant.
A number of mutagenesis studies aimed at clarifying for phosphorylation in this region (Wrana et al., 1994;
Souchelnytskyi et al., 1996). Furthermore, mutation ofthe role of the GS region in activation have been per-
formed (Feng et al., 1995; Wieser et al., 1995; Willis et either Thr-362 or Thr-364 to alanine or aspartate, as well
as mutation of both together, produces no significantal., 1996). Some of these results suggest that the GS
region, in addition to playing an inhibitory role when change in TGFb-induced signaling (data not shown),
indicating that activation segment phosphorylation isunphosphorylated, may also adopt a distinct activating
conformation upon phosphorylation. For example, dele- not required for receptor activation. Possible mecha-
nisms for modulating the conformation of the activationtion of the entire juxtamembrane region of TbR-I, includ-
ing the GS region, results in an inactive receptor, im- segment include interactions between the phosphory-
lated GS region and the activation segment, changesplying that a phosphorylated GS loop may be required
in the active state (Feng et al., 1995). Mutation of the in the quaternary arrangement of protomers within the
oligomeric receptor complex, or substrate binding.serines and threonines in the GS loop to aspartate de-
stroys signaling activity in TbR-I (Wieser et al., 1995),
suggesting that the activated GS loop conformation The TbR-I±FKBP12 Interaction
The TbR-I±FKBP12 structure is the first that capturesplaces particular structural requirements on these resi-
dues in addition to negative charge. Substitution of Thr- FKBP12 bound directly to a protein target. The confor-
mation of FKBP12 in the TbR-I±FKBP12 complex is es-204 with aspartate or glutamate creates a type I receptor
that is constitutively active and independent of the type sentially identical to that of FKBP12 seen in other struc-
tures (rmsd of 0.52 AÊ over Ca positions relative toII receptor (Wieser et al., 1995; Willis et al., 1996). Thr-
204 lies at the C terminus of the GS2 helix, well away FKBP12 bound to FK506, 0.63 AÊ for FKBP12 bound to
FK506 and calcineurin) (Van Duyne et al., 1991; Griffithfrom the GS loop and the catalytic center, and its role
in activation is not apparent from this structure (Figure et al., 1995; Wilson et al., 1995). Two conserved residues
in the TbR-I GS region, Leu-193 and Pro-194, are known4A). The molecular basis for these observations may
only become clear upon analyzing the conformation of to be required for FKBP12 binding (Charng et al., 1996;
Chen et al., 1997). The presence of a crucial proline in thethe GS region in the active, oligomeric receptor complex.
The configuration of the activation segment will also binding region is intriguing, since FKBP12 has proline
rotamase activity (Harrison and Stein, 1990). Howeverhave to change in order to relieve the steric blockage
to N lobe rotation and to remove Arg-372 from the active neither Leu-193 nor Pro-194 interacts directly with
FKBP12 in the structure of the complex. Rather, thesesite. Many kinases are activated by direct phosphoryla-
tion of the activation segment, which leads to a restruc- two residues appear to be important for stabilizing the
interface.turing that enables kinase activity (Johnson et al., 1996).
TbR-I contains two threonine residues (362 and 364) FKBP12 binds directly to Leu-195 and Leu-196, two
highly conserved residues situated at the N-terminal tipthat are potential sites for such phosphorylation. Phos-
phopeptide mapping of phosphorylated sites in acti- of the GS2 helix (Figure 2). It accommodates the two
aliphatic side chains in the same hydrophobic bindingvated receptor complexes has revealed no evidence
Crystal Structure of the TbR-I±FKBP12 Complex
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Figure 6. The TbR-I C Lobe Has Tyrosine Kinase±like Features
(A) A ribbon representation of PKA (Zheng et al., 1993) showing bound ATP and PKI substrate analog. The portion of the catalytic segment
(residues 164±172 in PKA) analyzed in (B) is colored green.
(B) The boxed region in (A) has been magnified to show the kinase active site. The N lobe and C lobe of PKA are shown in surface representation.
The catalytic segments of four Ser/Thr kinases (PKA, phosphorylase kinase, the MAP kinase p38, and Cdk2) (Zheng et al., 1993; Jeffrey et
al., 1995; Owen et al., 1995; Wang et al., 1997), four Tyr kinases (IRK, Hck, Src, and the FGF receptor) (Mohammadi et al., 1996; Hubbard,
1997; Sicheri et al., 1997; Xu et al., 1997), and TbR-I are shown based on an alignment of their C lobe helices. PKI and the IRK substrate are
shown as representative Ser/Thr and Tyr kinase substrates, respectively. A hypothetical serine has been modeled onto PKI using the position
of Ala-21. Nucleotides from the active PKA and IRK structures are also included. The catalytic segments cluster into two groups, and TbR-I
clusters with the Tyr kinases.
pocket used to engage macrolide (Figure 5), which is 1996; Chen et al., 1997; Stockwell and Schreiber, 1998b).
FKBP12 appears to act as a buffer, rather than an out-consistent with the ability of both rapamycin and FK506
to relieve FKBP12-mediated inhibition of TGFb signaling right antagonist, of the TGFb system, stabilizing and
prolonging the lifetime of downregulated TbR-I. The(Okadome et al., 1996; Wang et al., 1996; Chen et al.,
1997; Stockwell and Schreiber, 1998b). Leu-195 occu- TbR-I±FKBP12 structure is consistent with this role. As
has been suggested (Stockwell and Schreiber, 1998b),pies the same space as would the hemiketal ring of
FK506, while Leu-196 substitutes for the pipecolinyl such a buffering function may only become important
when receptor concentration is high enough to makemoiety. FKBP12 makes additional contacts with TbR-I
outside of the FK506-binding site (Figure 4B), and many ligand-independent activation a problem.
of these interactions are likely to be conserved in other
type I receptors. A Structural Link between TbR-I
and Tyrosine KinasesIt has been proposed that FKBP12 inhibits TGFb sig-
naling by occluding the type II receptor phosphorylation Comparison of the structures of the active serine/threo-
nine kinase PKA (Zheng et al., 1993) and the activesites in the type I receptor GS region (Chen et al., 1997).
While FKBP12 makes no direct contacts with residues tyrosine kinase insulin receptor kinase (IRK) (Hubbard,
1997) reveals that tyrosine kinases bind peptide sub-in the GS loop, it is positioned close enough to impede
the approach of a TbR-II kinase domain. Given the close strate further down in their C lobe (Figure 6). This change
allows tyrosine kinases to interpose the C-terminal endproximity of FKBP12 to the GS loop, it is also plausible
that GS loop phosphorylation induces FKBP12 dissocia- of their activation segment between the substrate and
the active site, thereby holding the substrate furthertion, as has been suggested (Wang et al., 1996; Chen
et al., 1997). away and providing a molecular basis for tyrosine speci-
ficity (Hubbard et al., 1994; Hubbard, 1997). This low-A recent report has detailed the analysis of FKBP12-
null mice (Shou et al., 1998). No apparent defect in TGFb ering of substrate peptide is mirrored by a z1 AÊ drop
in the catalytic segment of tyrosine kinases with respectsignaling was observed in fibroblasts taken from these
mice, and the authors suggest that the TbR-I±FKBP12 to the rest of the C lobe, which brings the entire ATP-
binding site and catalytic center down to the level of theinteraction has no physiological relevance. This conclu-
sion may be too strong. Indeed, a number of studies substrate. The change in the placement of the catalytic
segment relative to the C lobe results in a compensatoryhave shown that FKBP12 dissociation, while not suffi-
cient, is necessary for TbR-I activation (Wang et al., movement of the aE helix, which bulges out at its N
Cell
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terminus. These structural changes relative to Ser/Thr
kinases are conserved in all Tyr kinases of known
structure.
When the a helices in the C lobe of TbR-I are superim-
posed with those of other kinases, it becomes apparent
that TbR-I displays the same catalytic segment lowering
and E helix bulge characteristic of tyrosine kinases (Fig-
ure 6). TbR-I is able to phosphorylate serine and threo-
nine because it lacks a conserved proline (Pro-1172 in
IRK), which, in tyrosine kinases, kinks the activation
segment such that substrate is held further from the
active site. The tyrosine kinase±like disposition of the
catalytic segment and the C lobe, however, may explain
how the TGFb type II receptor can function as a dual
specificity kinase, at least under certain conditions in
vitro (Lawler et al., 1997).
The protein kinase of known structure most closely
related to TbR-I in terms of overall sequence identity is
the tyrosine kinase IRK, which shares 30% identity with
TbR-I over z250 aligned residues (Figure 2). The se-
quence identity between TbR-I and Ser/Thr kinases is
lower (e.g., z22% versus PKA, ERK2, and Cdk2). The
closer similarity between IRK and TbR-I in terms of se-
quence is reflected in the three-dimensional structure.
The a helices in the C lobe of TbR-I can be superimposed
upon the corresponding helices in IRK (Hubbard, 1997)
with a root-mean-square deviation of 1.3 AÊ for 102 Ca
atoms. The deviation for a similar alignment with PKA
(Zheng et al., 1993) is 1.8 AÊ .
The similarity between TGFb family receptors and ty-
rosine kinases suggests that an ancestor of the former
may represent a branch point in the evolution of tyrosine
kinases from cytoplasmic serine/threonine kinases. In-
terestingly, a transmembrane serine/threonine kinase
Figure 7. The TbR-I NCS Dimerhas been discovered in yeast. This protein, called Ire1p,
The dimer is viewed roughly down its two-fold axis. Gly-261 andis involved in the unfolded protein response (Shamu
Gly-322 are shown as magenta spheres. Above, the dimer is shownand Walter, 1996). However, the sequence of its kinase
in ribbon representation, and the N terminus of each protomer isdomain does not obviously place it in the TGFb receptor
indicated. Below, the molecular surface of the protomer on the left
superfamily (Hanks and Hunter, 1995). has been included to show the structural complementarity of the
dimer interface. FKBP12 is not involved in the formation of this
A Noncrystallographic TbR-I Dimer dimer and has been left out of this figure for clarity.
The active TGFb receptor complex contains homodimers
(or higher oligomers) of TbR-I in addition to homooligo-
burying a total accessible surface area of z1860 AÊ 2,mers of TbR-II (Chen and Derynck, 1994; Henis et al.,
compared to 1880 AÊ 2 for the TbR-I±FKBP12 interaction.1994; Yamashita et al., 1994; Luo and Lodish, 1996; Weis-
A majority of the dimerization contacts are made by theGarcia and MassagueÂ , 1996; Stockwell and Schreiber,
loop connecting helix aE and strand b6 (E6 loop), which1998a). Two residues in TbR-I, Gly-261 and Gly-322,
bears a characteristic insertion that is, for the most part,are required for a functional interaction between TbR-I
conserved among type I receptors (Figure 2). Further-subunits in the ligand-induced receptor complex (Weis-
more, the mutations described above map to the inter-Garcia and MassagueÂ , 1996). Substitution of these amino
face of this dimer. Gly-261 is located near the C terminusacids with glutamate and aspartate, respectively, results
of the loop connecting aC and b4 (C4 loop), while Gly-in a type I receptor that is inactive because it cannot be
322 maps to the very tip of the E6 loop. The N terminiphosphorylated by TbR-II. These activation-defective
of both molecules are oriented in the same direction,mutants can be complemented by cotransfection with
indicating that this dimer would not be inconsistent withkinase-inactive TbR-I that contains Gly-261 and Gly-
membrane attachment. Gly-261 and Gly-322 are both322. This implies that the mutations act in trans, some-
positioned next to conserved acidic side chains at thehow impeding GS region phosphorylation of the other
dimer interface. Glu-257 from the NCS-related moleculetype I receptor in the tetrameric signaling complex.
forms a hydrogen bond with the amide nitrogen of Gly-The importance of TbR-I homooligomerization moti-
322. Similarly, Gly-261 is positioned next to Asp-281, avated us to examine the TbR-I±FKBP12 crystal lattice
residue in the linker connecting b5 and aD. It is conceiv-for a potentially relevant dimer. One of the dimers gener-
able that the introduction of negatively charged sideated by noncrystallographic symmetry (NCS) is particu-
larly intriguing (Figure 7). Its interface is fairly extensive, chains at these sites could alter the dimer interface as
Crystal Structure of the TbR-I±FKBP12 Complex
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Table 1. Summary of Crystallographic Analysis
Multiple Isomorphous Replacement FKBP12 Placement
Native HgCl2 PCMB K2PtCl4 Native SeMet FKBP12
Resolution (AÊ ) 30.0±2.8 30.0±3.6 30.0±3.6 30.0±3.5 30.0±2.6 30.0±2.7
No. of sites Ð 12 8 4 Ð 12
Rsym (%)a overall (outer shell) 7.0 (19.4) 10.2 (23.4) 17.7 (34.8) 10.9 (27.6) 8.0 (24.3) 6.6 (18.1)
Completeness overall (outer shell) 97.1 (94.7) 96.9 (96.5) 98.1 (97.1) 96.8 (94.4) 98.4 (97.7) 94.8 (85.9)
I/s(I) overall (outer shell) 16.7 (4.8) 9.0 (3.2) 6.4 (2.9) 8.6 (2.8) 19.1 (6.0) 16.1 (4.9)
Riso(%)b Ð 23.2 18.0 21.4 Ð 9.8
Phasing powerc Ð 1.7 1.9 0.8 Ð Ð
Combined figure of merit (to 3.6 AÊ )d 0.42
Density Modification
Correlation for Correlation for Correlation for Final Correlation R Value for NCS
Operator #1e Operator #2 Operator #3 Coefficientf Averagingg
0.64 0.23 0.25 0.834 0.240
Refinement
Resolution No. of Reflections Total No. Rmsd for Rmsd for Rmsd for B
Range (|F|.2s) of Atoms Rworking/Rfreeh (%) Bonds (AÊ ) Angles (Deg.) Values (AÊ 2)
30.0±2.6 57,740 13,840 24.9/26.9 0.011 1.66 1.64
a Rsym% 5 100 3 S|I 2 ,I.|/SI, where I is the integrated intensity of a given reflection.
b Riso% 5 100 3 S|FPH 2 FP|/SFP, where FPH and FP are the derivative and native structure factor amplitudes, respectively.
c Phasing power 5 S|FH|/S||FPH (obs)| 2 |FPH (calc)||, where FH is the calculated heavy atom structure factor amplitude.
d Figure of merit 5 ,|SP(a)eia/S|P(a)|., where a is the phase and P(a) is the phase probability distribution.
e Correlation coefficient for an NCS operator 5 {S(ra 2 ,r.)(rb 2 ,r.)}/{S(ra 2 ,r.)2 S(rb 2 ,r.)2}1/2, where ra and rb represent electron
density related by the NCS operator in question.
f Correlation coefficient 5 {S(F(obs) 2 ,F(obs).)(F(calc) 2 ,F(calc).)}/{S(F(obs) 2 ,F(obs).)2S(F(calc) 2 ,F(calc).)2}1/2, where F(calc) repre-
sents the structure factor amplitudes obtained from back-transformation of NCS averaged maps.
g R value 5 S|F(obs) 2 F (calc)|/SF(obs), where F(calc) is defined as inf.
h R value 5 S|F(obs) 2 F (calc)|/SF(obs), where F(calc) represents the structure factor amplitudes obtained from back-transformation of the
model. The free R value was calculated using 10% of the data.
it is seen in the structure. This could, in turn, affect GS chains, as suggested by previous biochemical analyses
for the related type II receptor (Lawler et al., 1997).loop phosphorylation by TbR-II.
Members of the type I family of TGFb receptors are
also distinguished from receptor tyrosine kinases byConclusions
virtue of a unique regulatory mechanism, which involvesThe utilization of tyrosine kinases as receptors for poly-
phosphorylation by the type II receptors of a shortpeptide ligands is a specialization that is unique to in-
N-terminal segment (the GS region). Receptor tyrosinetercellular communication in metazoans (Hanks and
kinases are activated by phosphorylation within the cen-Hunter, 1995). It is notable that TGFb family receptors,
trally located activation segment of the kinase domain,which also transduce signals delivered by polypeptide
which blocks or distorts the active site when unphos-ligands, function as serine/threonine-specific rather
phorylated (Hubbard et al., 1994; Mohammadi et al.,than tyrosine-specific kinases. The classification of pro-
1996; Hubbard, 1997). In contrast, the regulatory GStein kinases on the basis of primary sequences had
region of TbR-I is located distal to the active site. Never-revealed a connection between the catalytic domains
theless, the GS region is seen to be coupled structurallyof receptors of the TGFb family and those of the tyrosine
to the activation segment by helix aC in the N lobe. Thekinases (Hanks and Hunter, 1995). The structure de-
manipulation of the aC helix and the activation segmentscribed here now makes clear that the location in TbR-I
by regulatory inputs is a common theme in protein ki-of the catalytic segment and, by implication, the bound
nase regulation (Jeffrey et al., 1995; Johnson et al., 1996;nucleotide, resembles that seen in tyrosine kinases
Sicheri et al., 1997; Xu et al., 1997), and in TbR-I therather than serine/threonine kinases. This result appears
displacement of aC by the unphosphorylated GS regionto be a consequence of dispersed changes in amino acid
is correlated with an inhibitory conformation of the acti-sequence rather than localized alterations of sequence
vation segment. The structure of TbR-I demonstratesmotifs. The idea that functional similarities can exist
that one key role for phosphorylation is to block thein the absence of subtype-specific residues has been
adoption of an inactivating configuration by the GS re-established by the analyses of various dual specificity
gion. The structure does, however, leave unansweredkinases (Lindberg et al., 1992). The TbR-I±FKBP12 struc-
the question of how the phosphorylated GS region par-ture illustrates how this phenomenon can be manifested
ticipates in the action of the assembled heteromericin three dimensions. The active site configuration of
receptor complex, which remains a challenge for futureTbR-I appears to be consistent with binding both tyro-
sine as well as the smaller serine and threonine side structural analyses.
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Experimental Procedures the unambiguous assignment of the FKBP12 methionine positions.
Two additional derivatives, K2PtCl4 and PCMB, were obtained and,
with the HgCl2 phases included, gave a combined initial figure ofProtein Expression and Purification
The cytoplasmic domain of human TbR-I (residues 162±503, hereaf- merit of 0.42.
Phases from the mercury and platinum derivatives were calcu-ter called TbR-I) was produced in SF9 cells using a baculoviral
expression system (Bac-to-Bac, GIBCO). Cells were lysed by son- lated to 3.6 AÊ using MLPHARE (CCP4, 1994) and SHARP (La Fortelle
and Bricogne, 1997). The initial experimental map was uninterpret-ication in 50 mM Tris (pH 8.5), 50 mM NaCl, 10 mM MgCl2, 8%
glycerol, 2 mM DTT, 1 mM phenyl-methyl sulphonyl fluoride. The able, but rough protomer±solvent boundaries could be distin-
guished. A protomer mask was generated in MAMA (Kleywegt andsoluble fraction of the lysate was applied to a Q sepharose column
attached in tandem with a g-phosphate conjugated ATP column. Q Jones, 1993), and the density was four-fold averaged using RAVE
(Kleywegt and Read, 1998). The resultant map confirmed the initialsepharose does not bind TbR-I under these conditions and func-
tioned as a subtractive step in the purification. After loading, the FKBP12 placement and allowed initiation of an iterative procedure
of model building, constrained refinement in CNS (BruÈ nger et al.,ATP column was eluted with a gradient of salt and EDTA. Fractions
containing TbR-I were pooled; the protein was concentrated by 1998), phase combination, mask improvement, and four-fold aver-
aging with phase extension to 3.0 AÊ .ultrafiltration and then applied to a Hiload Superdex 75 column
(Pharmacia). Purified TbR-I can be concentrated to 80 mg/ml. Refinement with tight NCS restraints was carried out using data
to 2.6 AÊ (X25, NSLS). Three rigid bodies (FKBP12, kinase N lobe,Full-length human FKBP12 was overexpressed in E. coli and puri-
fied using, in turn, Q sepharose, phenyl sepharose, and gel filtration and kinase C lobe) were used to define the NCS restraints. The
current model contains residues 1±107 of FKBP12 and 175±500 ofchromatography. Selenomethionine FKBP12 was prepared in a simi-
lar fashion, and full SeMet incorporation was confirmed by electro- TbR-I, a total of 13,840 nonhydrogen atoms, including 88 water
molecules and four sulfate ions. The average temperature factorsspray mass spectrometry. TbR-I±FKBP12 complex was generated
by adding an excess of FKBP12 to TbR-I and applying the resultant for all atoms of TbR-I and FKBP12 are 35 AÊ 2 and 42 AÊ 2, respectively.
Three small portions of the kinaseÐthe phosphate-binding loop,mixture to a sizing column equilibrated in 20 mM Tris (pH 7.5), 150
mM NaCl, 2 mM DTT. The two proteins coelute from a Superdex the L45 loop, and the very C terminusÐdisplay high temperature
factors (z80 AÊ 2). The electron density, though, is quite good in all75 HR 10/30 column (Pharmacia) as a stoichiometric complex.
of these regions with the exception of two residues at the very tip
of the L45 loop, G271 and T272, which exhibit the highest B factorsCrystallization and Data Collection
in the entire protein complex. The occupancies of some surfaceCrystallization trials using TbR-I alone yielded plate-like crystals that
side chain atoms (D269, Q324, K343, H371, and K391 from TbR-I;were difficult to handle and diffracted X-rays weakly. Subsequent
Q3 and K52 from FKBP12) have been set to 0 on account of poorproteolysis experiments showed that FKBP12 afforded TbR-I an
density. The model has been refined to a working R value of 24.9%appreciable amount of proteolytic protection, indicating that the
and a free R value of 26.9%. The R value is relatively high andTbR-I±FKBP12 complex would likely be a better crystallization tar-
reflects the fact that very tight NCS restraints were imposed for theget. Crystals of the TbR-I±FKBP12 complex were obtained at 208C
entire refinement (rms deviations of z0.003 AÊ between Ca positionsusing a reservoir solution of 100 mM Tris (pH 8.3±8.6), 1.40±1.53 M
for NCS-related rigid bodies in the final structures). 88.6% of protein(NH4)2SO4. TbR-I±FKBP12 complex was diluted to 20 mg/ml in a
residues are in the most favored regions of the Ramachandran plot,buffer containing 10 mM MgCl2 and 2 mM AMP-PNP. (Although not
with none in the disallowed regions.apparently incorporated into the crystals, the nucleotide slightly
improves crystal morphology.) Equal volumes of protein and reser-
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